Emma Morris is Professor of Clinical Cell & Gene Therapy at University College London. Professor Morris has made a significant contribution to the clinical translation of cell-based therapy for patients with immunodeficiencies. |At UCH she developed a critical infrastructure for clinical translation, including complex regulation and manufacturing. Her work led to the first clinical trial of T cell receptor-gene modified allogeneic cells for haematological malignancies. She leads the National Centre for Allogeneic haemopoietic stem cell transplantion in adults with primary immune deficiencies, and has been appointed National Clinical Lead for a new NHS England Commissioning Policy.|